DPP IV Inhibitors Market

DPP IV Inhibitors Market: Global Industry Analysis and Forecast 2015 - 2021

DPP IV Inhibitors Market Segmented By complications includes cardiovascular disease, nephropathy, retinopathy, and neuropathy can be treated using drugs include sitagliptin, vildagliptin, saxagliptin and linagliptin

Market Overview

DPP IV inhibitors are a class of hypoglycemic agents that block the enzyme named dipeptidyl peptidase IV. Dipeptidyl peptidase IV enzyme break down the proteins that are responsible for stimulating the insulin producing cells that slows down gastric secretion. Proteins can activate the release of insulin and can control the blood sugar level if DPP IV is inhibited in our body.

Moreover, DPP IV inhibitors restrict the formation of glucagon, a hormone that increases blood glucose level and thereby control the glucose levels in the body. DPP IV inhibitors are widely utilized as a treatment for type 2 diabetes. Sitagliptin, vildagliptin, saxagliptin and linagliptin are included in the drug class DPP IV. Nasopharyngitis, headache, nausea and hypersensitivity are some of the adverse effects due to the utilization of DPP IV.

Increasing prevalence of type 2 diabetes is a major public health concern worldwide. National Centre for Biotechnology Information in 2011 stated that in the U.S. more than 8% of the total population is diagnosed with diabetes. Diabetes is associated with a number of complications that includes cardiovascular disease, nephropathy, retinopathy, and neuropathy. Thus, the above mentioned factors derives the global DPP IV inhibitors market. However, the cost for DPP IV inhibitors is very high that might hinder the global DPP IV inhibitors market.

Geographically, North America and Europe dominates the global market for DPP IV inhibitors due to high prevalence rate and rising awareness among people about the DPP IV inhibitors. Asia – Pacific is considered as a fastest growing market due to increasing obese population.

Various key players contributing to the global DPP IV inhibitors market comprises Arisaph Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, Eli Lilly And Company, Bristol-Myers Squibb, Merck & Co, Inc., AstraZeneca Plc, Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceutical Company Limited and Novartis AG.

Find Out More about the Report Coverage

Key geographies evaluated in this report are:

  • North America
    • U.S
    • Canada
  • Europe
    • France, Germany, Italy, Spain, and the UK
    • Eastern Europe
    • CIS
  • APAC
    • China
    • India
    • Japan
    • Australia
    • Others
  • Latin America
    • Argentina
    • Brazil
    • Others

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Key features of this report

  • Drivers, restraints, and challenges shaping the DPP IV Inhibitors market dynamics
  • Latest innovations and key events in the industry
  • Analysis of business strategies of the top players
  • DPP IV Inhibitors market estimates and forecasts(2015 -2021)

Market Research Methodology - Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Get actionable insights on Ship Repair And Maintenance Services Market


Sterilization Services Market

Global Sterilization Services Market - explore share, size, revenue, valuation, CAGR, regional outlook, trends, key players, competitive landscape & forecast.

Delivery Systems In Personal Care Market

Delivery Systems In Personal Care Market report begins with sizing the market in terms of value and volume for the base year, which forms the basis for forecasting.

Pyrogen Testing Market

The market for global pyrogen testing is expected to grow at a robust 9% CAGR through 2029, as indicated by a recent forecast study..

Glucose Analysis Tubes Market

The global glucose analysis tubes market experienced noteworthy growth of 5.7% in 2021. As per Persistence Market Research’s analysis, sodium fluoride holds a substantial share of over 41% in the overall market..

Our Clients

Our Clients